The PEGASUS trial: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients

被引：17
|
作者：
Lonardi, S. [1 ]
Pietrantonio, F. [2 ]
Llavero, N. Tarazona [3 ]
Viladot, C. Montagut [4 ]
Bianchi, A. Sartore [5 ]
Zampino, M. G. [6 ]
Fernandez, M. E. Elez [7 ]
Vivas, C. Santos [8 ]
Mandala, M. [9 ]
Tamberi, S. [10 ]
Sciallero, M. S. [11 ]
Munoz, S. [12 ]
Lazzari, L. [13 ]
Luraghi, P. [13 ]
Torri, V. [14 ]
Cervantes, A.
Bardelli, A. [15 ]
Tabernero, J.
Siena, S.
Marsoni, S. [13 ]
机构：
[1] IOV Ist Oncol Veneto IRCCS, Oncol, Padua, Italy
[2] Fdn IRCCS, Dept Med Oncol, Ist Nazl Tumori, Milan, Italy
[3] Univ Valencia, INCLIVA Biomed Res Inst, Dept Med Oncol, Valencia, Spain
[4] Hosp Mar Parc Salut Mar, Dept Med Oncol, Barcelona, Spain
[5] Univ Milano La Statale, Dipartimento Oncol Emato Oncol, ASST Grande Osped Metropolitano Niguarda, Milan, Italy
[6] IEO Ist Europeo Oncol, Dept Med Oncol, Milan, Italy
[7] Vall Hebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
[8] Hosp Duran & Reynals, ICO Inst Catala Oncol Hosp, Med Oncol Dept, Lhospitalet De Llobregat, Spain
[9] Univ Perugia, Santa Maria Misericordia, Univ Hosp Perugia, Oncol, Perugia, Italy
[10] AUSL Romagna, Osped Infermi, Oncol Unit, Faenza, Ravenna, Italy
[11] IRCCS Osped Policlin San Martino, Med Oncol 1 Dept, Genoa, Italy
[12] Vall Hebron Inst Oncol VHIO, Cellex Ctr, Acad CRO, Barcelona, Spain
[13] IFOM AIRC Inst Mol Oncol, Precis Oncol Unit, Milan, Italy
[14] Ist Ric Farmacol Mario Negri IRCCS, Oncol, Milan, Italy
[15] IFOM AIRC Inst Mol Oncol, Gen Canc & Targeted Therapies, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA28
引用
收藏
页码：S1268 / S1269
页数：2
相关论文
共 50 条
  • [1] The PEGASUS trial: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients.
    Lonardi, Sara
    Montagut, Clara
    Pietrantonio, Filippo
    Elez, Elena
    Sartore-Bianchi, Andrea
    Tarazona, Noelia
    Sciallero, Stefania
    Zampino, M. Giulia
    Mosconi, Stefania
    Munoz, Susana
    Lazzari, Luca
    Luraghi, Paolo
    Siena, Salvatore
    Sobrero, Alberto F.
    Labianca, Roberto
    Torri, Valter
    Bardelli, Alberto
    Tabernero, Josep
    Marsoni, Silvia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] The effect of gaps in chemotherapy on survival in patients with high-risk stage II and stage III colon cancer
    Sada, Yvonne
    Duan, Zhigang
    El-Serag, Hashem
    Davila, Jessica
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [3] IDENTIFICATION OF HIGH-RISK PATIENTS IN STAGE II COLON CANCER
    Lanza, Giovanni
    Gafa, Roberta
    Santini, Alessandra
    Maestri, Iva
    Guerzoni, Laura
    Liboni, Alberto
    Azzena, Gianfranco
    Lelli, Giorgio
    Cavazzini, Luigi
    ANNALS OF ONCOLOGY, 2004, 15 : 66 - 66
  • [4] Biomarker for high-risk patients with stage II colon cancer
    Watanabe, Toshiaki
    LANCET ONCOLOGY, 2013, 14 (13): : 1247 - 1248
  • [5] Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer
    Moretto, Roberto
    Falcone, Alfredo
    Cremolini, Chiara
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (09) : 2652 - 2654
  • [6] A MICROSIMULATION MODEL FOR HIGH-RISK STAGE II AND STAGE III COLON CANCER SURVIVORS FOLLOWING THE CURRENT GUIDELINES
    Samur, S.
    Gursel, E.
    Gu, N. Y.
    Palomares, M.
    Sahinkoc, M.
    Hoban, O.
    Cuyun, Carter G.
    Ayer, T.
    Chhatwal, J.
    Parikh, A.
    Neugut, A., I
    VALUE IN HEALTH, 2024, 27 (06) : S14 - S14
  • [7] Adjuvant chemotherapy for high-risk stage II and stage III colon cancer: timing of initiation and optimal duration
    Cruz, Jan Paolo M.
    Pales, Chris George C.
    Kim, Kwang Min
    Kim, Young Wan
    JOURNAL OF BUON, 2018, 23 (03): : 568 - 573
  • [8] Identification of patients with high-risk stage II colon cancer for adjuvant therapy
    Quah, Hak-Mien
    Chou, Joanne F.
    Gonen, Mithat
    Shia, Jinru
    Schrag, Deborah
    Landmann, Ron G.
    Guillem, Jose G.
    Paty, Philip B.
    Temple, Larissa K.
    Wong, W. Douglas
    Weiser, Martin R.
    DISEASES OF THE COLON & RECTUM, 2008, 51 (05) : 503 - 507
  • [9] Study of a High-Risk Group of Stage II Colon Cancer
    Hirosawa, Tomoichiro
    Itabashi, Michio
    Bamba, Yoshiko
    Ogawa, Shinpei
    Sirotani, Noriyasu
    Kameoka, Shingo
    INTERNATIONAL SURGERY, 2009, 94 (02) : 130 - 135
  • [10] High-risk groups of patients with stage II colon carcinoma
    Merkel, S
    Wein, A
    Günther, K
    Papadopoulos, T
    Hohenberger, W
    Hermanek, P
    CANCER, 2001, 92 (06) : 1435 - 1443
12345